Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA.
J Immunol. 2011 Jun 15;186(12):6830-8. doi: 10.4049/jimmunol.1001049. Epub 2011 May 9.
Lung transplantation remains the only effective therapy for patients with end-stage pulmonary diseases. Unfortunately, acute rejection of the lung remains a frequent complication and is an important cause of morbidity and mortality. The induction of transplant tolerance is thought to be dependent, in part, on the balance between allograft effector mechanisms mediated by effector T lymphocytes (Teff), and regulatory mechanisms mediated by FOXP3(+) regulatory T cells (Treg). In this study, we explored an approach to tip the balance in favor of regulatory mechanisms by modulating chemokine activity. We demonstrate in an adoptive transfer model of lung rejection that CXCR3-deficient CD8(+) Teff have impaired migration into the lungs compared with wild-type Teff, which results in a dramatic reduction in fatal pulmonary inflammation. The lungs of surviving mice contained tolerized CXCR3-deficient Teff, as well as a large increase in Treg. We confirmed that Treg were needed for tolerance and that their ability to induce tolerance was dependent on their numbers in the lung relative to the numbers of Teff. These data suggest that transplantation tolerance can be achieved by reducing the recruitment of some, but not necessarily all, CD8(+) Teff into the target organ and suggest a novel approach to achieve transplant tolerance.
肺移植仍然是治疗终末期肺部疾病患者的唯一有效方法。不幸的是,肺的急性排斥反应仍然是一种常见的并发症,也是发病率和死亡率的重要原因。诱导移植耐受被认为部分依赖于效应 T 淋巴细胞 (Teff) 介导的同种异体效应机制与 FOXP3(+) 调节性 T 细胞 (Treg) 介导的调节机制之间的平衡。在这项研究中,我们探索了通过调节趋化因子活性来有利于调节机制的方法。我们在肺排斥的过继转移模型中证明,与野生型 Teff 相比,CXCR3 缺陷型 CD8(+)Teff 进入肺部的迁移能力受损,导致致命性肺部炎症显著减少。存活小鼠的肺部含有耐受的 CXCR3 缺陷型 Teff,以及 Treg 的大量增加。我们证实 Treg 是耐受所必需的,并且它们诱导耐受的能力取决于其在肺中的数量与 Teff 的数量之比。这些数据表明,通过减少某些但不是所有 CD8(+)Teff 进入靶器官,可以实现移植耐受,并提出了一种实现移植耐受的新方法。